학술논문

Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab.
Document Type
Article
Source
Dermatologic Therapy. Jul2022, Vol. 35 Issue 7, p1-3. 3p.
Subject
*TREATMENT effectiveness
*INFLIXIMAB
*GROIN pain
*LEUKOCYTE count
*PYODERMA gangrenosum
Language
ISSN
1396-0296
Abstract
Sneddon-Wilkinson disease, also known as subcorneal pustular dermatosis (SPD), is a rare neutrophilic dermatosis clinically characterized by vesico-pustular lesions often distributed in an annular or serpiginous pattern, which may evolve in superficial erosions resolving with scaling and residual dyspigmentation.1 It commonly involves flexural areas and abdomen in middle-aged women. Successful treatment of refractory Sneddon-Wilkinson disease (subcorneal pustular dermatosis) with infliximab Treatment of subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with anti-tumor necrosis factor alpha. [Extracted from the article]